Tolerability and acceptability of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: systematic review and meta-analysis
D Caldeira, N Goncalves, JJ Ferreira, FJ Pinto… - American Journal of …, 2015 - Springer
Background The non-vitamin K antagonist oral anticoagulants (NOACs) overcame some
limitations of vitamin K antagonists (VKAs), and are at least as effective in stroke prevention …
limitations of vitamin K antagonists (VKAs), and are at least as effective in stroke prevention …
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature
Background—Novel oral anticoagulants (NOACs) have been proposed as alternatives to
vitamin K antagonists for the prevention of stroke and systemic embolism in patients with …
vitamin K antagonists for the prevention of stroke and systemic embolism in patients with …
Practice-derived data on non-vitamin K antagonist oral anticoagulant therapy to complement observations from randomized trials
M Domek, J Gumprecht, WY Ding… - European Heart …, 2020 - academic.oup.com
Anticoagulation is fundamental in the management of patients with atrial fibrillation (AF). The
study aims to provide a comparative review of the major phase III randomized clinical trials …
study aims to provide a comparative review of the major phase III randomized clinical trials …
Non‐vitamin K antagonist oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with previous stroke or intracranial hemorrhage: A systematic …
Z Guo, X Ding, Z Ye, W Chen, Y Chen - Clinical Cardiology, 2021 - Wiley Online Library
Several observational studies have compared the effectiveness and safety outcomes
between nonvitamin K antagonist oral anticoagulants (NOACs) and vitamin K antagonists …
between nonvitamin K antagonist oral anticoagulants (NOACs) and vitamin K antagonists …
[HTML][HTML] Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends
Abstract Background Non-Vitamin K antagonist oral anticoagulants (NOACs) emerged as an
alternative with comparable or superior efficacy and safety to vitamin K antagonists (VKAs) …
alternative with comparable or superior efficacy and safety to vitamin K antagonists (VKAs) …
[HTML][HTML] Effectiveness and safety of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: Results of A real-world study in a metropolitan area of …
E Crocetti, S Cattaneo, W Bergamaschi… - Journal of Clinical …, 2021 - mdpi.com
Background: New oral anticoagulant agents (NOACs) are valid alternatives for vitamin K
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
Use of non‐vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic
Background Non‐vitamin K antagonist oral anticoagulants (NOAC s) are broadly preferable
to vitamin K antagonists (VKA s) for stroke prevention in non‐valvular atrial fibrillation (AF) …
to vitamin K antagonists (VKA s) for stroke prevention in non‐valvular atrial fibrillation (AF) …
Non-vitamin K antagonist oral anticoagulants in secondary stroke prevention in atrial fibrillation patients: an updated analysis by adding observational studies
Background This meta-analysis aimed to evaluate the efficacy and safety of non-vitamin K
antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (VKAs) in secondary …
antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (VKAs) in secondary …
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
J Steffel, P Verhamme, TS Potpara… - European heart …, 2018 - academic.oup.com
The current manuscript is the second update of the original Practical Guide, published in
2013 [Heidbuchel et al. European Heart Rhythm Association Practical Guide on the use of …
2013 [Heidbuchel et al. European Heart Rhythm Association Practical Guide on the use of …
Non–vitamin K antagonist oral anticoagulants for stroke prevention in Asian patients with nonvalvular atrial fibrillation: meta-analysis
KL Wang, GYH Lip, SJ Lin, CE Chiang - Stroke, 2015 - Am Heart Assoc
Background and Purpose—The use of vitamin K antagonists (VKAs), the cornerstone
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …